Form F-4/A Maius Pharmaceutical
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250613/A82ZW22CZC22T2NP222622E2MSJWZA22Z372
Filed on: June 13, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- ELEKTROS Inc. Extends a Heartfelt Father’s Day Blessing to Fathers Around the World
- Beyond 600 AI Employees: Tec-Do 2.0 Builds an Agent Skill Lab for Enterprise Productivity
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
